Literature DB >> 3060242

Serum bactericidal test.

C W Stratton1.   

Abstract

The serum bactericidal test represents one of the few in vitro tests performed in the clinical microbiology laboratory that combines the interaction of the pathogen, the antimicrobial agent, and the patient. Although the use of such a test antedates the antimicrobial era, its performance, results, and interpretation have been subject to question and controversy. Much of the confusion concerning the serum bactericidal test can be avoided by an understanding of the various factors which influence bactericidal testing. In addition, the methodologic aspects of the serum bactericidal test have recently been addressed and should place this test on firmer ground. New information on the clinical utility of this test is becoming available; additional data are needed to establish more clearly the usefulness of the serum bactericidal test in specific infections. Such clinical trials from multiple centers will enable firmer recommendations for the future use of the serum bactericidal test.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3060242      PMCID: PMC358026          DOI: 10.1128/CMR.1.1.19

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  95 in total

1.  Infective endocarditis caused by Streptococcus bovis resistant to the lethal effect of penicillin G.

Authors:  C B Savitch; A L Barry; P D Hoeprich
Journal:  Arch Intern Med       Date:  1978-06

2.  Effect of human serum on inhibition of growth of Staphylococcus aureus by antimicrobial agents.

Authors:  C W Stratton; M E Evans; D J Burch; H B Hawley; T A Horsman; K K Tu; L B Reller
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

3.  pH-dependent oxacillin tolerance of Staphylococcus aureus.

Authors:  J S Venglarcik; L L Blair; L M Dunkle
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

4.  Effect of the concentrations of magnesium and calcium on the in-vitro susceptibility of Pseudomonas aeruginosa to gentamicin.

Authors:  D N Gilbert; E Kutscher; P Ireland; J A Barnett; J P Sanford
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

5.  Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics.

Authors:  V P Syriopoulou; D W Scheifele; C M Sack; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

6.  Method of reliable determination of minimal lethal antibiotic concentrations.

Authors:  R D Pearson; R T Steigbigel; H T Davis; S W Chapman
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

7.  Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum.

Authors:  L G Reimer; C W Stratton; L B Reller
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

8.  Oral antibiotic therapy of skeletal infections in children.

Authors:  E Kolyvas; G Ahronheim; M I Marks; R Gledhill; H Owen; L Rosenthall
Journal:  Pediatrics       Date:  1980-05       Impact factor: 7.124

9.  Bactericidal activity and killing rate of serum in volunteers receiving teicoplanin alone or in combination with oral or intravenous rifampin.

Authors:  P Van der Auwera; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

10.  Oral antibiotic therapy for skeletal infections of children. II. Therapy of osteomyelitis and suppurative arthritis.

Authors:  T R Tetzlaff; G H McCracken; J D Nelson
Journal:  J Pediatr       Date:  1978-03       Impact factor: 4.406

View more
  9 in total

1.  Effects of supraphysiologic temperature and broth dilution on serum protein binding.

Authors:  R L White; M B Kays; T A Armstrong; L V Friedrich
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

2.  Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae.

Authors:  Paolo Gaibani; Donatella Lombardo; Michele Bartoletti; Simone Ambretti; Caterina Campoli; Maddalena Giannella; Sara Tedeschi; Matteo Conti; Rita Mancini; Maria Paola Landini; Maria Carla Re; Pierluigi Viale; Russell E Lewis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-06       Impact factor: 3.267

3.  Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers.

Authors:  D Israel; J G Gillum; M Turik; K Harvey; J Ford; H Dalton; M Towle; R Echols; A H Heller; R Polk
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

Review 4.  Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance.

Authors:  L R Peterson; C J Shanholtzer
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

Review 5.  Rifampin combination therapy for nonmycobacterial infections.

Authors:  Graeme N Forrest; Kimberly Tamura
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

6.  Pharmacokinetics and pharmacodynamics of newer oral cephalosporins: implications for treatment of community-acquired lower respiratory tract infections.

Authors:  M Cazzola; M G Matera; C F Donner
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 7.  Clinical implications of positive blood cultures.

Authors:  C S Bryan
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

8.  Serum Bactericidal Activity Levels Monitor to Guide Intravenous Dalbavancin Chronic Suppressive Therapy of Inoperable Staphylococcal Prosthetic Valve Endocarditis: A Case Report.

Authors:  Martina Spaziante; Cristiana Franchi; Gloria Taliani; Antonio D'Avolio; Valeria Pietropaolo; Elisa Biliotti; Rozenn Esvan; Mario Venditti
Journal:  Open Forum Infect Dis       Date:  2019-09-30       Impact factor: 3.835

9.  High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii.

Authors:  Massimiliano De Angelis; Maria T Mascellino; Maria C Miele; Dania Al Ismail; Marisa Colone; Annarita Stringaro; Vincenzo Vullo; Mario Venditti; Claudio M Mastroianni; Alessandra Oliva
Journal:  Antibiotics (Basel)       Date:  2022-02-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.